• Learning Objective 1: Review epidemiology and pathophysiology of OAB
  • Learning Objective 2: Review Initial Treatment Options for OAB
  • Learning Objective 3: Understand available Therapeutic Options for Refractory OAB
Session date: 
Friday, January 6, 2017 - 8:15am to 9:15am
Location: 
UCMC L-168 / L-272
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Juraj Letko